APOL1 genotyping in kidney transplantation: a look into the future
- 1 July 2021
- journal article
- editorial
- Published by Elsevier BV in Kidney International
- Vol. 100 (1), 32-34
- https://doi.org/10.1016/j.kint.2021.03.030
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- COVID-19–Associated Glomerular DiseaseJournal of the American Society of Nephrology, 2020
- Health Disparities in Kidney Transplantation for African AmericansAmerican Journal of Nephrology, 2017
- Social Determinants of Racial Disparities in CKDJournal of the American Society of Nephrology, 2016
- Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1Kidney International, 2015
- Plasma Apolipoprotein L1 Levels Do Not Correlate with CKDJournal of the American Society of Nephrology, 2014
- Risk of End-Stage Renal Disease Following Live Kidney DonationJAMA, 2014
- APOL1 Localization in Normal Kidney and Nondiabetic Kidney DiseaseJournal of the American Society of Nephrology, 2011
- A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9Kidney International, 2010
- Association of Trypanolytic ApoL1 Variants with Kidney Disease in African AmericansScience, 2010
- Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 geneHuman Genetics, 2010